Preliminary Effectiveness of Individual and Group MDMA-assisted Therapy for Israeli Veterans With PTSD and Moral Injury

This open-label trial (n=30) aims to explore the safety and preliminary effectiveness of MDMA-assisted therapy in Israeli veterans with PTSD and moral injury from special forces undercover units.

Conducted at HaEmek Medical Center, Israel, the study involves administering a flexible dose of methylenedioxymethamphetamine (MDMA) in individual and group treatment settings. Therapy teams trained by MAPS PBC will conduct the study with at least 30 participants, with the treatment period lasting approximately 18 weeks.

Participants will undergo three monthly experimental sessions, including two individual sessions and one group session, followed by integrative sessions of non-drug psychotherapy. The primary outcome measure is the change in PTSD Checklist for DSM-5 (PCL-5) scores from baseline to the final outcome visit, approximately 35 weeks post-baseline. The study aims to assess the safety, incidence, and frequency of adverse events, as well as the preliminary effectiveness of MDMA-assisted therapy in this population.

Topic PTSD
Compound MDMA
Country Israel
Visit trial

Trial Details



Trial Number

Sponsors & Collaborators

HaEmek Medical Center
HaEmek Medical Center, located in Afula, Israel, is a district general and teaching hospital affiliated with the Rappaport Faculty of Medicine. It was established on April 29, 1930, and has grown to serve about 700,000 residents in its region.

Data attribution

A large set of the trials in our database are sourced from ClinicalTrials.gov (CTG). We have modified these post to display the information in a more clear format or to correct spelling mistakes. Our database in actively updated and may show a different status (e.g. completed) if we have knowledge of this update (e.g. a published paper on the study) which isn't reflected yet on CTG. If a trial is not sourced from CTG, this is indicated on this page and you can follow the link to the alternative source of information.